Cardiol Therapeutics Inc (CRDL)
1.97
-0.01
(-0.51%)
USD |
NASDAQ |
May 08, 10:28
Cardiol Therapeutics EPS Diluted (TTM): -0.3257 for Dec. 31, 2023
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.3257 |
September 30, 2023 | -0.3186 |
June 30, 2023 | -0.3511 |
March 31, 2023 | -0.3401 |
December 31, 2022 | -0.3693 |
September 30, 2022 | -0.3518 |
June 30, 2022 | -0.4348 |
March 31, 2022 | -0.4868 |
December 31, 2021 | -0.5815 |
September 30, 2021 | -0.7559 |
June 30, 2021 | -0.6708 |
March 31, 2021 | -0.6343 |
Date | Value |
---|---|
December 31, 2020 | -0.5112 |
September 30, 2020 | -0.3643 |
June 30, 2020 | -0.3651 |
March 31, 2020 | -0.376 |
December 31, 2019 | -0.3992 |
September 30, 2019 | -0.6102 |
June 30, 2019 | -0.6772 |
March 31, 2019 | -0.6189 |
December 31, 2018 | -0.5329 |
September 30, 2018 | -0.2513 |
June 30, 2018 | -0.1048 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
-0.7559
Minimum
Sep 2021
-0.3186
Maximum
Sep 2023
-0.4697
Average
-0.3992
Median
Dec 2019
EPS Diluted (TTM) Benchmarks
Aurinia Pharmaceuticals Inc | -0.53 |
Acasti Pharma Inc | -4.578 |
Edesa Biotech Inc | -2.639 |
Lexaria Bioscience Corp | -0.68 |
Xenon Pharmaceuticals Inc | -2.72 |